The NICHD conducts and supports a variety of clinical research projects related to urinary tract health. Select a link below to learn more about these projects.
Featured NICHD Clinical Trial on Urinary Tract Health
- Refractory Overactive Bladder: Sacral Neuromodulation v. BoTulinum Toxin Assessment (ROSETTA) This study will compare the effectiveness of botulinum toxin A (Botox A®, Allergan) to that of sacral neuromodulation (InterStim®, Medtronic) in treating refractory urge UI. The study also will evaluate select technical attributes of the interventions and their effects on other lower urinary tract and pelvic floor symptoms.
NICHD Clinical Trials
ClinicalTrials.gov Search Results
Information on current NIH-sponsored clinical trials on UTIs and UI is available at the links below or by calling 1-800-411-1222.